Common steroids after ‘long COVID’ recovery may cut risk of death by up to 51%

Probe of DNA repeats reveals genetic link to schizophrenia
12 May 2022
New algorithm dramatically increases the speed of identifying two cancer drugs that work synergistically
12 May 2022

Common steroids after ‘long COVID’ recovery may cut risk of death by up to 51%

Evidence continues to gather that “long COVID,” that is, continued negative health impacts months after apparent recovery from severe COVID-19, is an important risk for some patients. For example, researchers from the University of Florida Gainesville showed last December that hospitalized patients who seemingly recovered from severe COVID-19 run more than double the risk of dying within the next year, compared to people who experienced only mild or moderate symptoms and who had not been hospitalized, or who never caught the illness.

Comments are closed.